Amy Beth Vanduyn Sells 1,762 Shares of Phreesia (NYSE:PHR) Stock

Key Points

• Amy Beth Vanduyn, SVP of Phreesia, sold 1,762 shares of the company's stock for a total of $41,019.36, resulting in a 1.54% decrease in her holdings.
• Phreesia recently reported quarterly earnings of $0.01 per share, beating expectations and showing a 14.9% revenue increase year-over-year.
• Analysts are generally optimistic, with a consensus rating of "Buy" and an average price target of $34.08 for Phreesia's stock.

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP Amy Beth Vanduyn sold 1,762 shares of the company's stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $41,019.36. Following the transaction, the senior vice president directly owned 112,479 shares in the company, valued at approximately $2,618,511.12. The trade was a 1.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Amy Beth Vanduyn also recently made the following trade(s):

• On Thursday, July 17th, Amy Beth Vanduyn sold 640 shares of Phreesia stock. The stock was sold at an average price of $26.89, for a total value of $17,209.60.

Phreesia Stock Performance

PHR traded up $0.87 during midday trading on Monday, hitting $24.74. 1,065,169 shares of the company traded hands, compared to its average volume of 1,230,749. The company's 50-day moving average is $27.51 and its 200 day moving average is $26.40. The company has a quick ratio of 2.12, a current ratio of 2.12 and a debt-to-equity ratio of 0.02. The firm has a market capitalization of $1.48 billion, a PE ratio of -58.90 and a beta of 0.72. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $32.76.

Phreesia (NYSE:PHR - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.01 EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.08. The business had revenue of $117.26 million during the quarter, compared to the consensus estimate of $116.39 million. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. The firm's revenue was up 14.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.03) EPS. Phreesia has set its FY 2026 guidance at EPS. On average, research analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on PHR shares. JMP Securities upped their price target on shares of Phreesia from $30.00 to $34.00 and gave the company a "market outperform" rating in a research report on Monday, September 8th. Piper Sandler upped their price objective on Phreesia from $33.00 to $34.00 and gave the stock an "overweight" rating in a research note on Friday, September 5th. Stephens reaffirmed an "overweight" rating and issued a $32.00 target price on shares of Phreesia in a report on Wednesday, September 3rd. DA Davidson raised Phreesia to a "strong-buy" rating in a research note on Monday, September 8th. Finally, Needham & Company LLC boosted their price objective on Phreesia from $29.00 to $35.00 and gave the company a "buy" rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating and twelve have assigned a Buy rating to the company. Based on data from MarketBeat.com, Phreesia has an average rating of "Buy" and a consensus target price of $34.08.

Institutional Investors Weigh In On Phreesia

Several large investors have recently made changes to their positions in the company. Raymond James Financial Inc. grew its holdings in shares of Phreesia by 2.7% during the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company's stock valued at $400,000 after buying an additional 375 shares during the last quarter. Diversified Trust Co increased its holdings in shares of Phreesia by 1.0% in the second quarter. Diversified Trust Co now owns 45,042 shares of the company's stock valued at $1,282,000 after purchasing an additional 426 shares during the period. PNC Financial Services Group Inc. raised its stake in shares of Phreesia by 2.8% in the second quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company's stock worth $569,000 after purchasing an additional 540 shares during the last quarter. Arcadia Investment Management Corp MI lifted its holdings in shares of Phreesia by 0.7% during the first quarter. Arcadia Investment Management Corp MI now owns 92,770 shares of the company's stock worth $2,371,000 after purchasing an additional 615 shares during the period. Finally, Oppenheimer Asset Management Inc. lifted its holdings in shares of Phreesia by 9.9% during the second quarter. Oppenheimer Asset Management Inc. now owns 8,803 shares of the company's stock worth $251,000 after purchasing an additional 792 shares during the period. 92.10% of the stock is owned by institutional investors.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.